Literature detail

Susceptibility of swine cells and domestic pigs to SARS-CoV-2.

David A Meekins1 Igor Morozov1 Jessie D Trujillo1 Natasha N Gaudreault1 Dashzeveg Bold1 Mariano Carossino2 Bianca L Artiaga1 Sabarish V Indran1 Taeyong Kwon1 Velmurugan Balaraman1 Daniel W Madden1 Heinz Feldmann3 Jamie Henningson1 Wenjun Ma1,4 Udeni B R Balasuriya2 Juergen A Richt1
Affiliations 4 institutions
  1. Center of Excellence for Emerging and Zoonotic Animal Diseases, Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
  2. Louisiana Animal Disease Diagnostic Laboratory and Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA.
  3. Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
  4. Department of Veterinary Pathobiology and Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.
PMID 33003988 2020 Emerg Microbes Infect eng ppublish
PubMed DOI Browse context

Article

Publication summary

The emergence of SARS-CoV-2 has resulted in an ongoing global pandemic with significant morbidity, mortality, and economic consequences. The susceptibility of different animal species to SARS-CoV-2 is of concern due to the potential for interspecies transmission, and the requirement for pre-clinical animal models to develop effective countermeasures. In the current study, we determined the ability of SARS-CoV-2 to (i) replicate in porcine cell lines, (ii) establish infection in domestic pigs via experimental oral/intranasal/intratracheal inoculation, and (iii) transmit to co-housed naïve sentinel pigs. SARS-CoV-2 was able to replicate in two different porcine cell lines with cytopathic effects. Interestingly, none of the SARS-CoV-2-inoculated pigs showed evidence of clinical signs, viral replication or SARS-CoV-2-specific antibody responses. Moreover, none of the sentinel pigs displayed markers of SARS-CoV-2 infection. These data indicate that although different porcine cell lines are permissive to SARS-CoV-2, five-week old pigs are not susceptible to infection via oral/intranasal/intratracheal challenge. Pigs are therefore unlikely to be significant carriers of SARS-CoV-2 and are not a suitable pre-clinical animal model to study SARS-CoV-2 pathogenesis or efficacy of respective vaccines or therapeutics.

coronavirus COVID-19 infection models pigs SARS-CoV-2 swine zoonotic disease Animals Betacoronavirus Cell Line Coronavirus Infections COVID-19 Disease Models, Animal Disease Reservoirs Disease Susceptibility Exome Sequencing Female Male

Structured evidence records

Evidence records

4 total
2 records
Extraction confidence 1.00
Key finding

SARS-CoV-2 replicated in porcine cell lines in vitro, demonstrating cell-level permissiveness.

Virus
Location
Not specified
Supporting text

SARS-CoV-2 was able to replicate in two different porcine cell lines with cytopathic effects.

Method
virus replication assay
Experimental system
in vitro cell culture
Extraction confidence 1.00
Key finding

Domestic pigs did not support SARS-CoV-2 infection following experimental oral, intranasal, and intratracheal inoculation.

Virus
Location
Not specified
Supporting text

None of the SARS-CoV-2-inoculated pigs showed evidence of clinical signs, viral replication or SARS-CoV-2-specific antibody responses.

Method
experimental infection; challenge study
Experimental system
in vivo animal experiment
1 records
Extraction confidence 0.90
Key finding

Experimental inoculation of pigs with SARS-CoV-2 did not result in transmission to co-housed sentinel pigs.

Virus
Location
Not specified
Supporting text

None of the SARS-CoV-2-inoculated pigs showed evidence of infection, and none of the sentinel pigs displayed markers of SARS-CoV-2 infection, indicating no transmission to co-housed naïve pigs.

Method
experimental infection; virus detection; serology
Study design
animal experiment
Transmission direction
animal-to-animal
1 records
Extraction confidence 0.90
Key finding

Experimentally inoculated pigs did not develop SARS-CoV-2-specific antibodies, showing no serological evidence of infection.

Virus
Host
Location
Not specified
Supporting text

None of the SARS-CoV-2-inoculated pigs showed evidence of clinical signs, viral replication or SARS-CoV-2-specific antibody responses.

Sample type
serum